Complications of mechanical thrombectomy for acute ischemic stroke: Incidence, risk factors, and clinical relevance in the Italian Registry of Endovascular Treatment in acute stroke.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 8 12 2020
medline: 12 11 2021
entrez: 7 12 2020
Statut: ppublish

Résumé

There are limited data concerning procedure-related complications of endovascular thrombectomy for large vessel occlusion strokes. We evaluated the cumulative incidence, the clinical relevance in terms of increased disability and mortality, and risk factors for complications. From January 2011 to December 2017, 4799 patients were enrolled by 36 centers in the Italian Registry of Endovascular Stroke Treatment. Data on demographic and procedural characteristics, complications, and clinical outcome at three months were prospectively collected. The complications cumulative incidence was 201 per 1000 patients undergoing endovascular thrombectomy. Ongoing antiplatelet therapy (p < 0.01; OR 1.82, 95% CI: 1.21-2.73) and large vessel occlusion site (carotid-T, p < 0.03; OR 3.05, 95% CI: 1.13-8.19; M2-segment-MCA, p < 0.01; OR 4.54, 95% CI: 1.66-12.44) were associated with a higher risk of subarachnoid hemorrhage/arterial perforation. Thrombectomy alone (p < 0.01; OR 0.50, 95% CI: 0.31-0.83) and younger age (p < 0.04; OR 0.98, 95% CI: 0.97-0.99) revealed a lower risk of developing dissection. M2-segment-MCA occlusion (p < 0.01; OR 0.35, 95% CI: 0.19-0.64) and hypertension (p < 0.04; OR 0.77, 95% CI: 0.6-0.98) were less related to clot embolization. Higher NIHSS at onset (p < 0.01; OR 1.04, 95% CI: 1.02-1.06), longer groin-to-reperfusion time (p < 0.01; OR 1.05, 95% CI: 1.02-1.07), diabetes (p < 0.01; OR 1.67, 95% CI: 1.25-2.23), and LVO site (carotid-T, p < 0.01; OR 1.96, 95% CI: 1.26-3.05; M2-segment-MCA, p < 0.02; OR 1.62, 95% CI: 1.08-2.42) were associated with a higher risk of developing symptomatic intracerebral hemorrhage compared to no/asymptomatic intracerebral hemorrhage. The subgroup of patients treated with thrombectomy alone presented a lower risk of symptomatic intracerebral hemorrhage (p < 0.01; OR 0.70; 95% CI: 0.55-0.90). Subarachnoid hemorrhage/arterial perforation and symptomatic intracerebral hemorrhage after endovascular thrombectomy worsen both functional independence and mortality at three-month follow-up (p < 0.01). Distal embolization is associated with neurological deterioration (p < 0.01), while arterial dissection did not affect clinical outcome at follow-up. Complications globally considered are not uncommon and may result in poor clinical outcome. Early recognition of risk factors might help to prevent complications and manage them appropriately in order to maximize endovascular thrombectomy benefits.

Sections du résumé

BACKGROUND
There are limited data concerning procedure-related complications of endovascular thrombectomy for large vessel occlusion strokes.
AIMS
We evaluated the cumulative incidence, the clinical relevance in terms of increased disability and mortality, and risk factors for complications.
METHODS
From January 2011 to December 2017, 4799 patients were enrolled by 36 centers in the Italian Registry of Endovascular Stroke Treatment. Data on demographic and procedural characteristics, complications, and clinical outcome at three months were prospectively collected.
RESULTS
The complications cumulative incidence was 201 per 1000 patients undergoing endovascular thrombectomy. Ongoing antiplatelet therapy (p < 0.01; OR 1.82, 95% CI: 1.21-2.73) and large vessel occlusion site (carotid-T, p < 0.03; OR 3.05, 95% CI: 1.13-8.19; M2-segment-MCA, p < 0.01; OR 4.54, 95% CI: 1.66-12.44) were associated with a higher risk of subarachnoid hemorrhage/arterial perforation. Thrombectomy alone (p < 0.01; OR 0.50, 95% CI: 0.31-0.83) and younger age (p < 0.04; OR 0.98, 95% CI: 0.97-0.99) revealed a lower risk of developing dissection. M2-segment-MCA occlusion (p < 0.01; OR 0.35, 95% CI: 0.19-0.64) and hypertension (p < 0.04; OR 0.77, 95% CI: 0.6-0.98) were less related to clot embolization. Higher NIHSS at onset (p < 0.01; OR 1.04, 95% CI: 1.02-1.06), longer groin-to-reperfusion time (p < 0.01; OR 1.05, 95% CI: 1.02-1.07), diabetes (p < 0.01; OR 1.67, 95% CI: 1.25-2.23), and LVO site (carotid-T, p < 0.01; OR 1.96, 95% CI: 1.26-3.05; M2-segment-MCA, p < 0.02; OR 1.62, 95% CI: 1.08-2.42) were associated with a higher risk of developing symptomatic intracerebral hemorrhage compared to no/asymptomatic intracerebral hemorrhage. The subgroup of patients treated with thrombectomy alone presented a lower risk of symptomatic intracerebral hemorrhage (p < 0.01; OR 0.70; 95% CI: 0.55-0.90). Subarachnoid hemorrhage/arterial perforation and symptomatic intracerebral hemorrhage after endovascular thrombectomy worsen both functional independence and mortality at three-month follow-up (p < 0.01). Distal embolization is associated with neurological deterioration (p < 0.01), while arterial dissection did not affect clinical outcome at follow-up.
CONCLUSIONS
Complications globally considered are not uncommon and may result in poor clinical outcome. Early recognition of risk factors might help to prevent complications and manage them appropriately in order to maximize endovascular thrombectomy benefits.

Identifiants

pubmed: 33283685
doi: 10.1177/1747493020976681
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-827

Auteurs

Giancarlo Salsano (G)

IRCCS San Martino Policlinic Hospital, Neuroradiology and Neurology, Genoa, Italy.

Giovanni Pracucci (G)

Department of NEUROFARBA, Neuroscience Section, University of Florence, Florence, Italy.

Nicola Mavilio (N)

IRCCS San Martino Policlinic Hospital, Neuroradiology and Neurology, Genoa, Italy.

Valentina Saia (V)

Neuroradiology Unit and Neurology and Stroke Unit, Santa Corona Hospital, Pietra Ligure, Italy.

Monica Bandettini di Poggio (M)

IRCCS San Martino Policlinic Hospital, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genoa, Italy.

Laura Malfatto (L)

IRCCS San Martino Policlinic Hospital, Neuroradiology and Neurology, Genoa, Italy.

Fabrizio Sallustio (F)

Imaging and Interventional Radiology and Stroke Unit, Policlinico Tor Vergata, Roma, Italy.

Andrea Wlderk (A)

Imaging and Interventional Radiology and Stroke Unit, Policlinico Tor Vergata, Roma, Italy.

Nicola Limbucci (N)

Interventional Neurovascular Unit and Stroke Unit, Ospedale Careggi-University Hospital, Firenze, Italy.

Patrizia Nencini (P)

Interventional Neurovascular Unit and Stroke Unit, Ospedale Careggi-University Hospital, Firenze, Italy.

Stefano Vallone (S)

Neuroradiology and Neurology, Ospedale Civile S. Agostino-Estense, University Hospital, Modena, Italy.

Andrea Zini (A)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center and Neuroradiology, Maggiore Hospital, Bologna, Italy.

Guido Bigliardi (G)

Neuroradiology and Neurology, Ospedale Civile S. Agostino-Estense, University Hospital, Modena, Italy.

Mariano Velo (M)

Neuroradiology and Stroke Unit, Department of Clinical and Experimental Medicine, University of Messina, Policlinico G. Martino Messina, Italy.

Isabella Francalanza (I)

Neuroradiology and Stroke Unit, Department of Clinical and Experimental Medicine, University of Messina, Policlinico G. Martino Messina, Italy.

Paola Gennari (P)

Neuroradiology and Neurology, 161157AOU Senese, Siena, Italy.

Rossana Tassi (R)

Neuroradiology and Neurology, 161157AOU Senese, Siena, Italy.

Mauro Bergui (M)

Interventional Neuroradiology Unit and Stroke Unit, Città della Salute e della Scienza-Molinette, Torino, Italy.

Paolo Cerrato (P)

Interventional Neuroradiology Unit and Stroke Unit, Città della Salute e della Scienza-Molinette, Torino, Italy.

Giuseppe Carità (G)

Neuroradiology and Neurology, Arcispedale S. Anna-University Hospital, Ferrara, Italy.

Cristiano Azzini (C)

Neuroradiology and Neurology, Arcispedale S. Anna-University Hospital, Ferrara, Italy.

Roberto Gasparotti (R)

Neuroradiology Unit and Stroke Unit, Spedali Civili, Brescia, Italy.

Mauro Magoni (M)

Neuroradiology Unit and Stroke Unit, Spedali Civili, Brescia, Italy.

Salvatore Isceri (S)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center and Neuroradiology, Maggiore Hospital, Bologna, Italy.

Christian Commodaro (C)

Department of Neuroradiology, Neurology and Stroke Unit, Cesena-Forlì, AUSL Romagna Azienda Ospedaliera, Cesena, Italy.

Francesco Cordici (F)

Department of Neuroradiology, Neurology and Stroke Unit, Cesena-Forlì, AUSL Romagna Azienda Ospedaliera, Cesena, Italy.

Roberto Menozzi (R)

Neuroradiology Unit and Stroke Unit, Ospedale Universitario, Parma, Italy.

Lilia Latte (L)

Neuroradiology Unit and Stroke Unit, Ospedale Universitario, Parma, Italy.

Mirco Cosottini (M)

Department of Translational Research and New Technologies in Medicine and Surgery, 9310University of Pisa, Pisa, Italy.

Michelangelo Mancuso (M)

Department of Translational Research and New Technologies in Medicine and Surgery, 9310University of Pisa, Pisa, Italy.

Alessio Comai (A)

Radiology Unit and Stroke Unit, Ospedale Centrale, Bolzano, Italy.

Enrica Franchini (E)

Radiology Unit and Stroke Unit, Ospedale Centrale, Bolzano, Italy.

Andrea Alexandre (A)

Institute of Neuroradiology and Neurology, A. Gemelli University Polyclinic, IRCCS and Foundation, Sacred Heart Catholic University, Rome, Italy.

Giacomo Della Marca (GD)

Institute of Neuroradiology and Neurology, A. Gemelli University Polyclinic, IRCCS and Foundation, Sacred Heart Catholic University, Rome, Italy.

Edoardo Puglielli (E)

Ospedale Civile Mazzini, Teramo, Italy.

Alfonsina Casalena (A)

Ospedale Civile Mazzini, Teramo, Italy.

Francesco Causin (F)

Stroke Unit and Neurosonology Laboratory, Department of Neuroscience, University of Padua School of Medicine, Padua, Italy.

Claudio Baracchini (C)

Stroke Unit and Neurosonology Laboratory, Department of Neuroscience, University of Padua School of Medicine, Padua, Italy.

Luca Di Maggio (L)

Neuroradiology and Neurology, 18698Ospedale San Giovanni Bosco, Torino, Italy.

Andrea Naldi (A)

Neuroradiology and Neurology, 18698Ospedale San Giovanni Bosco, Torino, Italy.

Andrea Grazioli (A)

UOC Neuroradiologia, DAI Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Stefano Forlivesi (S)

UOC Neuroradiologia, DAI Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Luigi Chiumarulo (L)

Interventional Neuroradiology Unit and Stroke Unit, Policlinico, Bari, Italy.

Marco Petruzzellis (M)

Interventional Neuroradiology Unit and Stroke Unit, Policlinico, Bari, Italy.

Giuseppina Sanfilippo (G)

Diagnostic and Interventional Neuroradiology Unit and Stroke Unit, IRCCS Mondino Foundation San Matteo Hospital, Pavia, Italy.

Gianpaolo Toscano (G)

Diagnostic and Interventional Neuroradiology Unit and Stroke Unit, IRCCS Mondino Foundation San Matteo Hospital, Pavia, Italy.

Nicola Cavasin (N)

Neuroradiology Unit and Neurology Unit, Ospedale dell'Angelo, USSL3 Serenissima, Mestre, Italy.

Critelli Adriana (C)

Neuroradiology Unit and Neurology Unit, Ospedale dell'Angelo, USSL3 Serenissima, Mestre, Italy.

Maria Porzia Ganimede (MP)

Interventional Radiology Unit and Stroke Unit, Ospedale SS. Annunziata, Taranto, Italy.

Maria Pia Prontera (MP)

Interventional Radiology Unit and Stroke Unit, Ospedale SS. Annunziata, Taranto, Italy.

Giorgianni Andrea (G)

Neuroradiology Unit and Stroke Unit, Ospedale Universitario Circolo, ASST Sette Laghi, Varese, Italy.

Marco Mauri (M)

Neuroradiology Unit and Stroke Unit, Ospedale Universitario Circolo, ASST Sette Laghi, Varese, Italy.

William Auteri (W)

Interventional Neuroradiology Unit and Neurology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.

Alfredo Petrone (A)

Interventional Neuroradiology Unit and Neurology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.

Carlo Cirelli (C)

Department of Human Neurosciences, Interventional Neuroradiology and Neurology, Università degli Studi di Roma Sapienza, Roma, Lazio, Italy.

Anne Falcou (A)

Department of Human Neurosciences, Interventional Neuroradiology and Neurology, Università degli Studi di Roma Sapienza, Roma, Lazio, Italy.

Simona Corraine (S)

Neuroscience Department, Azienda Ospedaliera G. Brotzu, Cagliari, Sardinia, Italy.

Valeria Piras (V)

Neuroscience Department, Azienda Ospedaliera G. Brotzu, Cagliari, Sardinia, Italy.

Giuseppe Ganci (G)

Neuroradiology Unit and Neurology and Stroke Unit, Santa Corona Hospital, Pietra Ligure, Italy.

Tiziana Tassinari (T)

Neuroradiology Unit and Neurology and Stroke Unit, Santa Corona Hospital, Pietra Ligure, Italy.

Nunzio Paolo Nuzzi (NP)

IRCCS Humanitas Clinical and Research Center, Rozzano, Milano, Italy.

Manuel Corato (M)

IRCCS Humanitas Clinical and Research Center, Rozzano, Milano, Italy.

Simona Sacco (S)

Department of Clinical Scieces and Biotechnology, Presidio Ospedaliero SS. Filippo e Nicola, Avezzano, Italy.

Guido Squassina (G)

Neuroradiology Unit and Stroke Unit, Spedali Civili, Brescia, Italy.

Paolo Invernizzi (P)

Neuroradiology Unit and Stroke Unit, Spedali Civili, Brescia, Italy.

Ivan Gallesio (I)

Department of Radiology and Neuroradiological Unit, Department of Neurology, Azienda ospedaliera "SS Antonio e Biagio e C. Arrigo," Alessandria, Italy.

Delfina Ferrandi (D)

Department of Radiology and Neuroradiological Unit, Department of Neurology, Azienda ospedaliera "SS Antonio e Biagio e C. Arrigo," Alessandria, Italy.

Giovanni Dui (G)

Radiology and Interventional Radiology Unit and Neurology Unit, 97998Ospedale San Francesco, Nuoro, Italy.

Gianluca Deiana (G)

Radiology and Interventional Radiology Unit and Neurology Unit, 97998Ospedale San Francesco, Nuoro, Italy.

Pietro Amistà (P)

Department of Neuroradiology and Neurology, Hospital of Rovigo, Rovigo, Italy.

Monia Russo (M)

Department of Neuroradiology and Neurology, Hospital of Rovigo, Rovigo, Italy.

Francesco Pintus (F)

Unit of Neuroradiology and Stroke Unit, Santissima Annunziata Hospital, Sassari, Italy.

Antonio Baule (A)

Unit of Neuroradiology and Stroke Unit, Santissima Annunziata Hospital, Sassari, Italy.

Giuseppe Craparo (G)

Department of Neuroradiology and Neurology, AOOR Villa Sofia-V. Cervello, Palermo, Italy.

Marina Mannino (M)

Department of Neuroradiology and Neurology, AOOR Villa Sofia-V. Cervello, Palermo, Italy.

Lucio Castellan (L)

IRCCS San Martino Policlinic Hospital, Neuroradiology and Neurology, Genoa, Italy.

Danilo Toni (D)

Emergency Department Stroke Unit, Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Salvatore Mangiafico (S)

Interventional Neurovascular Unit and Stroke Unit, Ospedale Careggi-University Hospital, Firenze, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH